Santa Rosa, CA, United States of America

Danforth Joslyn


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Danforth Joslyn: Innovator in Angiogenic Implant Technology

Introduction

Danforth Joslyn is a notable inventor based in Santa Rosa, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of angiogenic implant systems. With a total of 2 patents to his name, Joslyn's work focuses on enhancing blood flow in tissues through innovative implant delivery methods.

Latest Patents

Danforth Joslyn's latest patents include an "Angiogenic Implant Delivery System and Method" and a "Method of Enhancing Blood Flow in Tissue." The angiogenic implant delivery system is designed to deliver an implant to the tissue that needs treatment. This system features a housing, a movable delivery head that carries the implant, and an actuator for controlling the delivery head's position. Additionally, it includes a depth gauge to measure how far the implant is inserted into the tissue. The method of enhancing blood flow involves non-ablatively introducing an implant into the tissue to stimulate the production of angiogenic agents. These agents are absorbed into the implant and released back into the tissue when their production subsides. The implant is made from a bioresorbable material, ensuring it is resorbed into the tissue after the agents are released.

Career Highlights

Danforth Joslyn is currently associated with Neovasys, Inc., where he continues to innovate in the field of medical devices. His work has the potential to significantly impact the treatment of various medical conditions related to blood flow and tissue health.

Collaborations

Some of his notable coworkers include Theodore L Parker and Serjan D Nikolic, who contribute to the collaborative efforts at Neovasys, Inc. Their combined expertise enhances the development of advanced medical technologies.

Conclusion

Danforth Joslyn's contributions to angiogenic implant technology demonstrate his commitment to improving medical treatments. His innovative patents reflect a deep understanding of the complexities involved in enhancing blood flow in tissues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…